Clinical trial

Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy

NCT00309894

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BIOLOGICAL · Unmapped registry intervention sargramostim Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record ketoconazole Normalized identity: ketoconazoleView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention therapeutic hydrocortisone Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-04-01

PhasePHASE2

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

sargramostimBIOLOGICAL

ketoconazoleDRUG · verified · RxNorm: ketoconazole

therapeutic hydrocortisoneDRUG

Sponsors & collaborators

University of California, San Franciscolead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

San FranciscoCalifornia, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00309894 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.